AVMA news
VCPR requirements fuel state legislative activity
The issue of whether to establish a veterinarian-client-patient-relationship (VCPR) through an in-person examination or solely electronic means has…
AVMA news
Unlawful xylazine receives more scrutiny to prevent inclusion in illegal drugs
Regulators and legislators are showing greater interest in xylazine, a prescription drug used in multiple sectors of clinical veterinary medicine,…
Animal health advocacy
The AVMA’s advocacy work provides critical support for the work veterinary teams do every day to protect, promote, and advance animal health. Learn…
blog
Congressional offices consider making xylazine a controlled substance
With illicit xylazine increasingly showing up in street drugs that pose grave risks to human users, government policymakers are discussing making it a…
blog
New COVID-19 stimulus supports veterinary profession
The COVID-19 relief package enacted March 11 contains AVMA-championed provisions that are critical to supporting veterinary professionals and…
JAVMA news
AAFCO calls for more research on hemp products in animal food
The Association of American Feed Control Officials has issued a position paper and call to action on hemp and its byproducts in livestock feed and pet…
AVMA news
AVMA CEO addresses workforce trends
Speaking to animal health industry leaders this August, AVMA CEO Dr. Janet Donlin talked about the challenges and opportunities facing the veterinary…
AVMA news
Raw pet food diets, pet population management policies headed to HOD
The AVMA House of Delegates, during its regular winter session, being held January 5-6, 2024, in Chicago, will vote on six resolutions that would…